STANLEY L. SCHRIER, M.D.
This content is PDF only. Please click on the PDF icon to access.
The recent report in this journal of the National Institutes of Health (NIH) Consensus Development Conference on the use of thrombolytic therapy (1) and the accompanying editorial note by Victor Marder (2) have suggested that fibrinolytic agents may not be used often enough. Dr. Marder argues that the hazards of fibrinolytic agents have been misinterpreted and quotes the hematology section of the Medical Knowledge Self-Assessment Program (MKSAP) V Syllabus (3), which states that the use of fibrinolytic agents "carries a 40% to 50% risk of serious hemorrhage." As the chairman of the MKSAP V committee that wrote the hematology section
SCHRIER SL. Thrombolytic Therapy. Ann Intern Med. ;93:629–630. doi: 10.7326/0003-4819-93-4-629
Download citation file:
Published: Ann Intern Med. 1980;93(4):629-630.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use